Moleculin Biotech (MBRX) Assets (2015 - 2026)
Moleculin Biotech (MBRX) recorded Assets of $21.09 million in Q2 2026, down 2.3% from $21.59 million a year earlier.
Powered by 
Analysis
Moleculin Biotech (MBRX) Assets (2015 - 2026) Analysis & Trends
At the end of FY2025, Moleculin Biotech reported Assets of $22.13 million, up 30.7% from FY2024.
- Annual Assets has a five-year compound annual growth rate of -5.3% (FY2020 to FY2025).
- Across earlier years, Assets came in at $16.93 million in FY2024 (-55.7%), $38.22 million in FY2023 (-33.4%), $57.42 million in FY2022 (-31.7%) and $84.09 million in FY2021 (+189.7%).
- Quarterly Assets has ranged from $16.93 million in Q4 2024 to $88.7 million in Q3 2021 over the past five years.
- On a year-over-year basis, Assets rose in 1 of the last seven quarters, with an average decline of 18.4%.
- Peak year-over-year performance for Assets in the last five years was growth of 226.8% in Q3 2021, against a decline of 55.7% in Q4 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Moleculin Biotech | 3.24 Mn | 3.24 Mn | - | 21.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.09 Mn |
| Dec 31, 2025 | 22.13 Mn |
| Sep 30, 2025 | 20.35 Mn |
| Jun 30, 2025 | 21.59 Mn |
| Mar 31, 2025 | 21.01 Mn |
| Dec 31, 2024 | 16.93 Mn |
| Sep 30, 2024 | 23.39 Mn |
| Jun 30, 2024 | 25.58 Mn |
| Mar 31, 2024 | 30.85 Mn |
| Dec 31, 2023 | 38.22 Mn |
| Sep 30, 2023 | 39.52 Mn |
| Jun 30, 2023 | 47.12 Mn |
| Mar 31, 2023 | 51.06 Mn |
| Dec 31, 2022 | 57.42 Mn |
| Sep 30, 2022 | 65.37 Mn |
| Jun 30, 2022 | 73.26 Mn |
| Mar 31, 2022 | 78.80 Mn |
| Dec 31, 2021 | 84.09 Mn |
| Sep 30, 2021 | 88.70 Mn |
| Jun 30, 2021 | 93.53 Mn |
API Access
Moleculin Biotech Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=MBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "MBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=MBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();